❓ How can clinical trials for rare respiratory diseases be faster and more effective? Join Francis Jones, Terri Denissen, Alex Auais, and Gino Pirri from Thermo Fisher Scientific to explore how AI, real-world data, and strategic trial design are overcoming challenges in idiopathic pulmonary fibrosis (IPF) and other rare respiratory diseases. Learn how innovations in patient recruitment, retention, and trial execution improve outcomes and accelerate development. Register now: https://buff.ly/CQAO